


investing in high yielding corporate and
| Name | % Net Assets | 
|---|---|
| Boots 5.5% £ Bonds 26/5/2009 | 1.8% | 
| VNU 5.625% £ MTN 20/5/2010 | 1.3% | 
| Rhodia € FRN 15/10/2013 | 1.3% | 
| Linde 8.125% £ Bonds 14/7/2016 | 1.3% | 
| GlaxoSmithKline | 1.3% | 
| AstraZeneca | 1.3% | 
| NTL Cable 9.75% £ Bonds 15/4/2014 | 1.2% | 
| SLM 5.375% £ Bonds 15/12/2010 | 1.2% | 
| BG | 1.1% | 
| BP | 1.1% | 
| Key | % Net Assets | 
|---|---|
| 1.8% | |
| 1.3% | |
| 1.3% | |
| 1.3% | |
| 94.3% | 
| Date | 26-May-2017 | 
|---|---|
| NAV | 388.71p | 
| Currency | GBP | 
| Change | 0.000p | 
| % | n/a | 
| YTD change | 388.71p | 
| YTD % | n/a | 
| Fund Inception | 06/02/1999 | 
|---|---|
| Fund Manager | Paul Causer / Paul Read / Neil Woodford | 
| TER | 1.44 (31-Dec-2013) | 
| Minimum Investment | |
|---|---|
| Initial | £500 | 
| Additional | £100 | 
| Savings | £20 | 
| Charges | |
|---|---|
| Initial | 5.00% | 
| Annual Mang't | 1.42% | 
| Exit | n/a | 
| Name | % | 
|---|---|
| Standard deviation | 0.00 | 
| Sharpe ratio | 0.61 | 
You are here: research